Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2018 1
2019 1
2020 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
A Risk Assessment Tool for Predicting Fragility Fractures in People with HIV: Derivation and Internal Validation of the FRESIA Model.
Vizcarra P, Moreno A, Vivancos MJ, Muriel García A, Ramirez Schacke M, González-Garcia J, Curran A, Palacios R, Sánchez Guirao AJ, Reus Bañuls S, Moreno Guillén S, Casado JL; Spanish HIV Research Network (CoRIS). Vizcarra P, et al. J Bone Miner Res. 2023 Oct;38(10):1443-1452. doi: 10.1002/jbmr.4894. Epub 2023 Aug 23. J Bone Miner Res. 2023. PMID: 37545089 Free article.
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study.
Serrano-Villar S, Martínez-Sanz J, Ron R, Talavera-Rodríguez A, Fernández-Felix BM, Herrera S, Muriel A, Fanjul F, Portilla J, Muñoz J, Amador C, de Zárraga MA, Vivancos MJ, Moreno S; Spanish HIV Research Network (CoRIS). Serrano-Villar S, et al. Lancet HIV. 2020 Aug;7(8):e565-e573. doi: 10.1016/S2352-3018(20)30202-2. Lancet HIV. 2020. PMID: 32763219 Clinical Trial.
Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
Suárez-García I, Sobrino-Vegas P, Dalmau D, Rubio R, Iribarren JA, Blanco JR, Gutierrez F, Montero Alonso M, Bernal E, Vinuesa García D, Del Amo J; Cohort of the Spanish HIV Research Network (CoRIS). Suárez-García I, et al. Addiction. 2016 Jul;111(7):1235-45. doi: 10.1111/add.13348. Epub 2016 Apr 14. Addiction. 2016. PMID: 26890155
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients.
Portocarrero Nuñez JA, Gonzalez-Garcia J, Berenguer J, Gallego MJV, Loyarte JAI, Metola L, Bernal E, Navarro G, Del Amo J, Jarrín I; and the Cohort of the Spanish HIV Research Network (CoRIS). Portocarrero Nuñez JA, et al. Medicine (Baltimore). 2018 Sep;97(38):e12238. doi: 10.1097/MD.0000000000012238. Medicine (Baltimore). 2018. PMID: 30235668 Free PMC article.
Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen.
Jarrin I, Hernández-Novoa B, Alejos B, Santos I, Lopez-Aldeguer J, Riera M, Gutiérrez F, Rubio R, Antela A, Blanco JR, Moreno S; Cohort of the Spanish HIV Research Network (CoRIS). Jarrin I, et al. HIV Med. 2014 Oct;15(9):547-56. doi: 10.1111/hiv.12144. Epub 2014 Mar 24. HIV Med. 2014. PMID: 24655804 Free article.
Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015.
Suárez-García I, González J, Berenguer J, García F, Portilla J, Muga R, Moreno S, Jarrín I; Cohort of the Spanish HIV Research Network (CoRIS). Suárez-García I, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2019 Nov;37(9):580-587. doi: 10.1016/j.eimc.2019.02.007. Epub 2019 Apr 11. Enferm Infecc Microbiol Clin (Engl Ed). 2019. PMID: 30982676 English, Spanish.